Epistaxis

Search with Google Search with Bing
Information
Disease name
Epistaxis
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03912051 Completed N/A Assessment of Performance and Safety of an Asymmetric Balloon in the Treatment of Intranasal Bleeding Managed in an Emergency Setting March 27, 2019 July 18, 2019
NCT02517294 Completed N/A , "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?" June 2015 August 2019
NCT02638012 Completed N/A Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) December 2015 December 2019
NCT00863356 Completed N/A Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis March 2009 June 2009
NCT03092973 Completed Carotid Intima Media Thickness (CIMT) in Epistaxis December 1, 2016 June 30, 2017
NCT03360045 Completed Phase 4 Comparing Effectiveness of Merocel and Packing With Tranexamic Acid in the Management of Anterior Epistaxis May 1, 2018 August 1, 2018
NCT03740620 Completed N/A The Effect of Bevel Direction on the Pathway of the Nasotracheal Tube January 14, 2019 March 31, 2020
NCT04426409 Completed N/A Nasal Ointment on Epistaxis of Nasotracheal Intubation in Children July 8, 2020 September 1, 2021
NCT04279288 Completed N/A The Roles of Hilotherapy in the Management of Epistaxis and Nasal Fractures May 1, 2018 August 1, 2019
NCT04167085 Completed Phase 4 NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial December 18, 2017 June 1, 2021
NCT04217941 Completed N/A Effect of Practical Demonstration to Use Nasal Spray and Apply Intranasal Ointment on Epistaxis June 1, 2018 December 1, 2018
NCT01098578 Completed N/A Floseal Treatment for Posterior Epistaxis Study April 2010 November 2011
NCT01314274 Completed Phase 2 Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) March 2011 June 2013
NCT01408030 Completed Phase 2 North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) August 2011 September 2014
NCT01408732 Completed Phase 1/Phase 2 Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia February 2011 September 2014
NCT01485224 Completed Phase 2 Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia November 2011 October 11, 2016
NCT00793117 Completed Phase 4 The Effect of Packing in Post Operative Management of FESS November 2008 December 2010
NCT02285634 Completed N/A The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial. November 2014 December 22, 2017
NCT02315677 Completed N/A Nasal Intubation Using a Parker Flex-tip Endotracheal Tube Compared to a Nasal RAE Tube January 2015 November 2015
NCT02338102 Completed N/A Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer January 2013 May 2015
NCT02370381 Completed Hemoglobin and INR Out of Nose Blood February 2015 June 2015
NCT02389959 Completed Phase 4 Intranasal Bevacizumab for HHT-Related Epistaxis August 4, 2014 January 23, 2020
NCT05334017 Completed Phase 4 Xylometazoline and Cocaine for Nasal Vasoconstriction September 8, 2022 March 22, 2023
NCT02488135 Completed N/A Management of Persistent Epistaxis Using Floseal Hemostatic Matrix July 1, 2015 March 1, 2017
NCT05343650 Not yet recruiting Phase 4 NOVAPAK Nasal Packing in Shellfish Allergic Patients March 15, 2024 May 15, 2025
NCT03850730 Not yet recruiting Phase 1/Phase 2 Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia July 1, 2023 December 31, 2025
NCT06259292 Recruiting Comprehensive HHT Outcomes Registry of the United States (CHORUS) November 13, 2023 November 2033
NCT03850964 Recruiting Phase 2/Phase 3 Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) May 8, 2023 March 31, 2026
NCT05281952 Recruiting N/A Medico-economic Evaluation of Management Strategies for Severe Epistaxis May 1, 2023 December 2026
NCT05269849 Recruiting Phase 2 Sirolimus for Nosebleeds in HHT March 16, 2022 February 10, 2025
NCT04054687 Suspended Phase 2 Intranasal TXA for Anterior Epistaxis in the Emergency Department November 7, 2019 May 2021
NCT01051427 Terminated N/A Control of Epistaxis With Surgiflo March 2010 August 2012
NCT00666471 Terminated Phase 2/Phase 3 Minimally Invasive Control of Epistaxis (MICE) June 2008 June 2009
NCT00814333 Terminated N/A Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis December 2008 August 2011
NCT02106520 Terminated Phase 2/Phase 3 Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) April 2014 September 2015
NCT02930941 Terminated Phase 4 Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department February 2016 December 31, 2020
NCT00390663 Unknown status Phase 4 A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children October 2006
NCT03788460 Unknown status Correlation Between PT and INR to Factor 7 January 7, 2019 January 2020
NCT04519463 Unknown status Early Phase 1 The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing September 2020 December 2022
NCT02963129 Unknown status Phase 3 Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT June 2017 December 2017
NCT02677467 Unknown status Correlation Between Epistaxis and Cardiovascular Disease March 2016 August 2016
NCT04151888 Unknown status Hot Water Irrigation in Posterior Epistaxis January 30, 2020 June 30, 2021
NCT01886768 Unknown status N/A Double Versus Single Pledget Nasal Anesthesia for Transnasal Endoscopy September 2012 February 2014
NCT02466464 Withdrawn N/A Microporous Polysaccharide Hemospheres Epistaxis January 1, 2015 December 31, 2015
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0000421
ICD10 preferred id (Insert disease from ICD10)
D0014948
ICD10 class code (Insert disease from ICD10)
R04.0
MeSH unique ID (MeSH (Medical Subject Headings))
D004844